An analysis of the exclusion criteria used in observational pharmacoepidemiology studies

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 3, 2007, Pages 329-336

  Perrio, Michael ^a   Waller, Patrick C ^a   Shakir, Saad A W ^a,b  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Adverse drug reactions; Case control studies; Cohort studies; Exclusion; Patient selection; Pharmacoepidemiology

Indexed keywords

ANTIHYPERTENSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE DISTRIBUTION; ARTICLE; CANCER; CASE CONTROL STUDY; COHORT ANALYSIS; DRUG EXPOSURE; DRUG SAFETY; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; MEDICAL LITERATURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PUBLICATION; RESEARCH ETHICS; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING; VALIDATION PROCESS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CASE-CONTROL STUDIES; COHORT STUDIES; ELIGIBILITY DETERMINATION; HUMANS; PATIENT SELECTION; PHARMACOEPIDEMIOLOGY; RESEARCH DESIGN; RISK FACTORS;

EID: 33947233327     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1262     Document Type: Article

References (20)

1. McMahon AD, MacDonald TM. Design issues for drug epidemiology. Br J Clin Pharmacol 2000; 50: 419-425. DOI: 10. 1046/j. 1365-2125.2000.00289.x
2. Kaufman DW, Shapiro S. Epidemiological assessment of drug-induced disease. Lancet 2000; 356: 1339-1343. DOI: 10. 1016/SO 140-6736(00)02826-9
3. Posternak MA, Zimmerman M, Keitner GI, Miller IW. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am J Psychiatry 2002; 159: 191-200.
4. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002; 159: 469-473.
5. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. Br Med J 1997; 315(7115): 1059.
6. Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. Br Med J 2000; 321: 992-993.
7. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-1422.
8. Jick H, García-Rodriguez LA, Perez-Gutthann S. Principles of epidemiological research on adverse and beneficial drug effects. Lancet 1998; 352: 1767-1770. DOI:10.1016/SO140-6736(98)04350-5
9. Jick H, Vessey MP. Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol 1978; 107(1): 1-7.
10. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003; 158(9): 915-920.
11. Rothman KJ, Ray WA. Should cases with a 'known' cause of their disease be excluded from study? Pharmacoepidemiol Drug Saf 2002; 11: 11-14. DOI: 10.1002/pds.683
12. Horwitz RI, Feinstein AR. Exclusion bias and the false relationship of reserpine and breast cancer. Arch Intern Med 1985; 145: 1873-1875.
13. Lubin JH, Hartge P. Excluding controls: misapplications in case-control studies. Am J Epidemiol 1984; 120(5): 791-793.
14. Poole C. Controls who experienced hypothetical causal intermediates should not be excluded from case-control studies. Am J Epidemiol 1990; 150(6): 547-551.
15. Evans JMM, MacDonald TM. Misclassification bias and selection bias in case-control studies using an automated database. Pharmacoepidemiol Drug Saf 1997; 6: 313-318. DOI: 10.1002/(SICI)1099-1557(199709/10)6:5<313
16. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004; 329: 883-889. DOI:10.1136/bmj.38250.571088.55
17. STROBE Checklist version 3 (September 2005). http://www.strobe-statement.org/PDF/STROBE-Checklist-Version3.pdf [last accessed 11/01/06]
18. Sanders KM, Pasco JA, Ugoni AM, et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong osteoporosis study. J Bone Miner Res 1998; 13(8): 1337-1342.
19. Grimes DA, Schulz KF, Bias and causal associations in observational research. Lancet 2002; 359: 248-252. DOI:10.1016/S0140-6736(02)07451-2
20. Tierney JF, Stewart LA. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 2005; 34: 79-87. DOI: 10. 1093/ije/dyh300